Alto Neuroscience Inc (ANRO) Implied Volatility Current

Tracking ANRO implied volatility helps you identify when options premiums on Alto Neuroscience Inc are historically cheap or expensive, and where the best trades are hiding. Alto Neuroscience Inc implied volatility reflects the market's expectation of future price movement: when ANRO IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Alto Neuroscience Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ANRO, tracking metrics like ANRO IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ANRO signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company develops ALTO-100 for the treatment of patients with major depressive disorder (MDD) and post-traumatic stress disorder; ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties to treat patients with MDD; and ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor for the treatment of cognitive impairment associated with schizophrenia. It also develops ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist to treat patients with MDD and higher levels of anhedonia, and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor for the treatment of MDD.

In addition, the company develops novel pharmacodynamically synergistic combinations and an AI-enabled biomarker platform that combine sources of information on patients brain activity and behavior to identify patients to respond to novel product candidates. Alto Neuroscience, Inc. was incorporated in 2019 and is based in Los Altos, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ANRO implied volatility sits today versus where it has been. Our scanner ranks Alto Neuroscience Inc implied volatility against its historical range, surfaces extremes in ANRO IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Alto Neuroscience Inc IV is rich or cheap — measure it, then act on it.